Literature DB >> 8121417

Analysis of the fimB promoter region involved in type 1 pilus phase variation in Escherichia coli.

W R Schwan1, H S Seifert, J L Duncan.   

Abstract

Many strains of Escherichia coli express type 1 pili which undergo phase variation during growth in broth, but become uniformly nonpiliated when passaged on agar media. In a previous analysis of these agar phase locked strains, we demonstrated that fimB and fimE, which mediate the site-specific DNA rearrangement involved in phase variation, are differentially transcribed under the two growth conditions. In this study the fimB promoter region was sequenced and characterized in agar phase locked strain J96. Primer extension analysis of the fimB gene identified three putative transcription initiation sites. Transcription starting from two of the sites (P1 and P2) would produce an mRNA that approximates the transcript size of fimB previously detected by Northern blot hybridizations. Gel mobility shift studies revealed the presence of promoter binding activity in broth-grown cell extracts, but not in extracts from agar-grown cells, that reacted specifically with DNA fragments upstream of the P1 and P2 promoter regions. This putative binding protein may be involved in the regulation of fimB, perhaps by acting as a transcriptional activator.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8121417     DOI: 10.1007/bf00285286

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  27 in total

1.  Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli.

Authors:  J P DUGUID; I W SMITH; G DEMPSTER; P N EDMUNDS
Journal:  J Pathol Bacteriol       Date:  1955-10

2.  A 23-kilodalton protein, distinct from BvgA, expressed by virulent Bordetella pertussis binds to the promoter region of vir-regulated toxin genes.

Authors:  Y J Huh; A A Weiss
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control.

Authors:  B I Eisenstein
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

4.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  The fimA gene encoding the type-1 fimbrial subunit of Escherichia coli. Nucleotide sequence and primary structure of the protein.

Authors:  P Klemm
Journal:  Eur J Biochem       Date:  1984-09-03

6.  Identification and characterization of a gene product that regulates type 1 piliation in Escherichia coli.

Authors:  P E Orndorff; S Falkow
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

7.  Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli.

Authors:  B I Eisenstein; D S Sweet; V Vaughn; D I Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Growth conditions mediate differential transcription of fim genes involved in phase variation of type 1 pili.

Authors:  W R Schwan; H S Seifert; J L Duncan
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

9.  Selective outgrowth of fimbriate bacteria in static liquid medium.

Authors:  D C Old; J P Duguid
Journal:  J Bacteriol       Date:  1970-08       Impact factor: 3.490

10.  Nucleotide sequence of pilA, the gene encoding the structural component of type 1 pili in Escherichia coli.

Authors:  P E Orndorff; S Falkow
Journal:  J Bacteriol       Date:  1985-04       Impact factor: 3.490

View more
  9 in total

1.  Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli.

Authors:  William R Schwan; Jeffrey L Lee; Farrah A Lenard; Brian T Matthews; Michael T Beck
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Authors:  Kyle A Floyd; Courtney A Mitchell; Allison R Eberly; Spencer J Colling; Ellisa W Zhang; William DePas; Matthew R Chapman; Matthew Conover; Bridget R Rogers; Scott J Hultgren; Maria Hadjifrangiskou
Journal:  J Bacteriol       Date:  2016-09-09       Impact factor: 3.490

3.  Promoter-specific repression of fimB expression by the Escherichia coli nucleoid-associated protein H-NS.

Authors:  G M Donato; M J Lelivelt; T H Kawula
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

4.  Integrated regulatory responses of fimB to N-acetylneuraminic (sialic) acid and GlcNAc in Escherichia coli K-12.

Authors:  Baljinder K Sohanpal; Sammia El-Labany; Maryam Lahooti; Jacqueline A Plumbridge; Ian C Blomfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

5.  Coordinate expression of fimbriae in uropathogenic Escherichia coli.

Authors:  Jennifer A Snyder; Brian J Haugen; C Virginia Lockatell; Nathalie Maroncle; Erin C Hagan; David E Johnson; Rodney A Welch; Harry L T Mobley
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment.

Authors:  Ann E Rentschler; Steven D Lovrich; Robert Fitton; Jodi Enos-Berlage; William R Schwan
Journal:  Microbiology       Date:  2012-11-22       Impact factor: 2.777

7.  Regulation of fim genes in uropathogenic Escherichia coli.

Authors:  William R Schwan
Journal:  World J Clin Infect Dis       Date:  2011-12-30

8.  Temporal Regulation of fim Genes in Uropathogenic Escherichia coli during Infection of the Murine Urinary Tract.

Authors:  William R Schwan; Hua Ding
Journal:  J Pathog       Date:  2017-12-27

9.  Virulence factors of uropathogens and their role in host pathogen interactions.

Authors:  Deenadayalan Karaiyagowder Govindarajan; Kumaravel Kandaswamy
Journal:  Cell Surf       Date:  2022-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.